During the past decade, Abertawe Bro Morgannwg University Health Board conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Abertawe Bro Morgannwg University Health Board" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "ADC Therapeutics S.A." with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Kevin Munro" with 1 trials sponsored and "Queen Mary University of London" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Abertawe Bro Morgannwg University Health Board" #1 collaborator was "Achieve Life Sciences" with 1 trials as a collaborator, "Göteborg University" with 1 trials as a collaborator, "National Institute of Dental and Craniofacial Research (NIDCR)" with 1 trials as a collaborator, "University of Copenhagen" with 1 trials as a collaborator and "University of Liverpool" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Abertawe Bro Morgannwg University Health Board" are "Nonalcoholic Steatohepatitis" (2 trials), "Cleft Palate" (1 trials), "Crohn's Disease" (1 trials), "Crohn's Enteritis" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Abertawe Bro Morgannwg University Health Board" in a lesser frequency.

Most popular intervention types in "Abertawe Bro Morgannwg University Health Board" are "Drug" (6 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials), "SEL" (2 trials), "Apatorsen (OGX-427)" (1 trials) and "BMS-986165" (1 trials). Other intervention names were less common.

The vast majority of trials in "Abertawe Bro Morgannwg University Health Board" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Abertawe Bro Morgannwg University Health Board". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Abertawe Bro Morgannwg University Health Board, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Abertawe Bro Morgannwg University Health Board, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".